Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case series

Published:2022-12 Issue:12 Volume:10 Page:3317-3319
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Perlato Margherita,Mecheri Valentina,Accinno Matteo,Vivarelli Emanuele,Matucci Andrea,Vultaggio Alessandra

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference13 articles.

1. Hypersensitivity reactions to mAbs:105 desensitization in 23 patients, from evaluation to treatment;Brennan;J Allergy Clin Immunol,2009

2. Clinical features and severity grading of anaphylaxis;Brown;J Allergy Clin Immunol,2004

3. Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab;Vultaggio;Int Arch Allergy Immunol,2012

4. Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis;Villarreal-González;J Oncol Pharm Pract,2021

5. Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab;Matucci;Clin Exp Allergy,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab/omalizumab/rituximab;Reactions Weekly;2023-06-10

2. Therapeutical Targets in Allergic Inflammation;Biomedicines;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP